Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,320 | 18,575 | 31,013 | 29,854 | 40,387 |
| Receivables | N/A | 17 | N/A | 131 | 3 |
| Inventories | 459 | 506 | 642 | 679 | 1,525 |
| Other current assets | 934 | 995 | 1,385 | 1,440 | 1,398 |
| TOTAL | $44,403 | $25,243 | $37,777 | $37,394 | $47,792 |
| Non-Current Assets | |||||
| PPE Net | 249 | 324 | 399 | 475 | 552 |
| Other Non-Current Assets | 140 | 222 | 390 | 469 | 548 |
| TOTAL | $389 | $546 | $789 | $944 | $1,100 |
| Total Assets | $44,792 | $25,789 | $38,566 | $38,338 | $48,892 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 16,823 | 11,216 | 5,608 | N/A | N/A |
| Accounts payable and accrued liabilities | 16,398 | 16,814 | 15,569 | 16,097 | 14,996 |
| Accrued Expenses | 4,363 | 5,090 | 3,986 | 5,762 | 10,193 |
| Other current liabilities | 220 | 256 | 383 | 374 | 368 |
| TOTAL | $37,804 | $33,376 | $25,546 | $22,233 | $25,557 |
| Non-Current Liabilities | |||||
| Long Term Debt | 92,302 | 97,469 | 99,918 | 102,508 | 104,440 |
| Other Non-Current Liabilities | 3,605 | 2,611 | 3,274 | 6,698 | 4,528 |
| TOTAL | $95,907 | $100,080 | $103,192 | $109,206 | $108,968 |
| Total Liabilities | $133,711 | $133,456 | $128,738 | $131,439 | $134,525 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,869 | 14,557 | 6,056 | 5,486 | 2,672 |
| Common Shares | 73 | 60 | 59 | 49 | 42 |
| Retained earnings | -707,549 | -676,638 | -657,451 | -650,197 | -639,338 |
| TOTAL | $-88,919 | $-107,667 | $-90,172 | $-93,101 | $-85,633 |
| Total Liabilities And Equity | $44,792 | $25,789 | $38,566 | $38,338 | $48,892 |